For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Arcellx Inc (NASDAQ: ACLX) closed the day trading at $51.09 down -7.63% from the previous closing price of $55.31. In other words, the price has decreased by -$7.63 from its previous closing price. On the day, 0.55 million shares were traded. ACLX stock price reached its highest trading level at $54.72 during the session, while it also had its lowest trading level at $50.32.
Ratios:
For a better understanding of ACLX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.46 and its Current Ratio is at 5.46. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on May 31, 2024, initiated with a Overweight rating and assigned the stock a target price of $70.
On March 07, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $81.
Needham reiterated its Buy rating for the stock on January 04, 2024, while the target price for the stock was revised from $65 to $71.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 01 ’24 when Heery Christopher sold 20,000 shares for $60.42 per share. The transaction valued at 1,208,435 led to the insider holds 9,278 shares of the business.
Patel Kavita sold 1,500 shares of ACLX for $92,949 on Jul 30 ’24. The Director now owns 0 shares after completing the transaction at $61.97 per share. On Jul 16 ’24, another insider, Heery Christopher, who serves as the CHIEF MEDICAL OFFICER of the company, sold 10,901 shares for $65.30 each. As a result, the insider received 711,854 and left with 9,278 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACLX now has a Market Capitalization of 2733447936 and an Enterprise Value of 2472670208. For the stock, the TTM Price-to-Sale (P/S) ratio is 20.76 while its Price-to-Book (P/B) ratio in mrq is 5.48. Its current Enterprise Value per Revenue stands at 18.78 whereas that against EBITDA is -33.966.
Stock Price History:
Over the past 52 weeks, ACLX has reached a high of $75.10, while it has fallen to a 52-week low of $30.88. The 50-Day Moving Average of the stock is -9.72%, while the 200-Day Moving Average is calculated to be -8.72%.
Shares Statistics:
Over the past 3-months, ACLX traded about 464.37K shares per day on average, while over the past 10 days, ACLX traded about 373630 shares per day. A total of 52.28M shares are outstanding, with a floating share count of 40.11M. Insiders hold about 25.04% of the company’s shares, while institutions hold 75.93% stake in the company. Shares short for ACLX as of 1721001600 were 4998228 with a Short Ratio of 10.76, compared to 1718323200 on 4809180. Therefore, it implies a Short% of Shares Outstanding of 4998228 and a Short% of Float of 10.71.
